Penumbra (NYSE:PEN) versus Micron Solutions (OTCMKTS:MICR) Financial Survey

Penumbra (NYSE:PEN) and Micron Solutions (OTCMKTS:MICR) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.

Insider and Institutional Ownership

88.9% of Penumbra shares are held by institutional investors. 5.0% of Penumbra shares are held by insiders. Comparatively, 26.1% of Micron Solutions shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility & Risk

Penumbra has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Micron Solutions has a beta of 0.04, suggesting that its share price is 96% less volatile than the S&P 500.

Valuation and Earnings

This table compares Penumbra and Micron Solutions”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.40 billion	9.38	$177.69 million	$4.52	74.26
Micron Solutions	N/A	N/A	N/A	($0.32)	0.00

Penumbra has higher revenue and earnings than Micron Solutions. Micron Solutions is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Penumbra and Micron Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Penumbra	12.66%	11.41%	8.83%
Micron Solutions	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations for Penumbra and Micron Solutions, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0	14	4	0	2.22
Micron Solutions	0	0	0	0	0.00

Penumbra currently has a consensus target price of $361.69, indicating a potential upside of 7.76%. Given Penumbra’s stronger consensus rating and higher probable upside, research analysts plainly believe Penumbra is more favorable than Micron Solutions.

Summary

Penumbra beats Micron Solutions on 11 of the 12 factors compared between the two stocks.

About Penumbra

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

About Micron Solutions

Micron Solutions, Inc. operates as a contract manufacturer for the medical device, defense, and life sciences markets. It offers precision machining, thermoplastic injection molding, mold making products; sensors; orthopedic implants and devices; and diagnostic test kits. The company provides solutions for medical, orthopedics, consumer, and automotive industries. Micron Solutions, Inc. was founded in 1978 and is based in Fitchburg, Massachusetts.